임신 중 비정상 자궁경부 세포검사를 보인 여성의 처치
Management of Women with Abnormal Pap Smear Tests in Pregnancy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pregnancy provides a unique opportunity for young women to begin participating in the National Cancer Screening Program. The incidence of abnormal Pap smear test results during pregnancy is approximately 5%, and is comparable to that in non-pregnant women. However, normal physiological changes of the cervix during pregnancy can complicate the diagnostic accuracy of the Pap smear test, and prevent appropriate management in women who yield an abnormal test result. To date, no large, prospective clinical trials evaluating the management of women with abnormal Pap smear tests in pregnancy have been performed. Herein, we review and summarize a large series of literature and consensus guidelines on the evaluation of abnormal Pap smear test results and the management of cervical neoplasia in pregnancy.
Abstract
Pregnancy provides a unique opportunity for young women to begin participating in the National Cancer Screening Program. The incidence of abnormal Pap smear test results during pregnancy is approximately 5%, and is comparable to that in non-pregnant women. However, normal physiological changes of the cervix during pregnancy can complicate the diagnostic accuracy of the Pap smear test, and prevent appropriate management in women who yield an abnormal test result. To date, no large, prospective clinical trials evaluating the management of women with abnormal Pap smear tests in pregnancy have been performed. Herein, we review and summarize a large series of literature and consensus guidelines on the evaluation of abnormal Pap smear test results and the management of cervical neoplasia in pregnancy.
참고문헌 (28)
- Ahdoot D, "The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period", Am J Obstet Gynecol, 178, pp.1116~1120 (1998)
- Amant F, "Gynecologic cancers in pregnancy:guidelines of an international consensus meeting", Int J Gynecol Cancer, 19(Suppl 1), pp.S1~S12 (2009)
- Arbyn M, "Chapter 9: clinical application of HPV testing : a summary of meta-analyses", Vaccine, 24(suppl 3), pp.S78~S89 (2006)
- ASCUS-LSIL Triage Stduy (ALTS) Group, "Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance", Am J Obstet Gynecol, 188, pp.1383~1392 (2003)
- Campion MJ, "Colposcopy in pregnancy", Obstet Gyencol Clin North Am, 20, pp.153~163 (1993)
- Cox JT, "Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy", Am J Obstet Gynecol, 188, pp.1406~1412 (2003)
- Economos K, "Abnormal cervical cytology in pregnancy: a 17-year experience", Obstet Gynecol, 81, pp.915~918 (1993)
- Fader AN, "Cervical dysplasia in pregnancy: a multi-institutional evaluation", Am J Obstet Gyenecol, 203, pp.113~ (2010)
- Hannigan EV, "Cone biopsy during pregnancy", Obstet Gyencol, 60, pp.450~455 (1982)
- Jeda Y, "Postpartum outcome of cervical intraepithelial neoplasia in pregnant women determined by route of delivery", Reprod Sci, 16(11), pp.1034~1039 (2009)
- Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
- Kaneshiro BE, "Effect of delivery route on natural history of cervical dysplasia", Am J Obstet Gynecol, 192, pp.1452~1454 (2005)
- Kaplan KJ, "Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesion diagnosed during pregnancy", Cancer, 102, pp.228~232 (2004)
- 이재관, "Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition", Journal of Gynecologic Oncology, 24(2), pp.186~203 (2013), 대한부인종양학회
- Lee JK, "Comparison of human papillomavirus detection and typing by hybrid capture 2, linear arry, DNA chip, and cycle sequencing in cervical swab samples", Int J Gynecol Cancer, 19, pp.266~272 (2009)
- Young Hwa Lee, "Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009", Journal of Gynecologic Oncology, 23(1), pp.16~21 (2012), 대한부인종양학회
- Massad LS, "2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors", J Low Genit Tract Dis, 17(5), pp.S1~S27 (2013)
- Michael CW, "Pregnancy-related changes: a retrospective review of 278 cervical smears", Diagn Cytopathol, 17, pp.99~107 (1997)
- Numnum TM, "A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?", J Low Genit Dis, 9, pp.2~6 (2005)
- Parkin DM, "Estimating the world cancer burden: Globocan 2000", Int J Cancer, 94, pp.153~156 (2001)
- Patridge EE, "Cervcial cancer screening", J Natl Compr Netw, 8, pp.1358~1386 (2010)
- 설현주, "Epidemiologic characteristics of cervical cancer in Korean women", Journal of Gynecologic Oncology, 25(1), pp.70~74 (2014), 대한부인종양학회
- Serati M, "Natural history of cervical intraepithelial neoplasia during pregnancy", Acta Obstet Gynecol Scand, 87, pp.1296~1300 (2008)
- Sharpless KE, "Dysplasia associated with atypical glandular cells on cervical cytology", Obstet Gynecol, 105, pp.494~500 (2005)
- Vlahos G, "Conservative mamangement of cervical intraepithelial neoplasia (CIN(2-3)) in pregnant women", Gynecol Obstet Invest, 54, pp.78~81 (2002)
- Wetta LA, "The management of cervical intraepithelial neoplasia during pregnancy: is colposcopy necessary?", J Low Genit Tract Dis, 13, pp.182~185 (2009)
- Wright TC, "2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests", Am J Obstet Gynecol, 197, pp.340~345 (2007)
- Yost NP, "Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions", Obstet Gyencol, 93(3), pp.359~362 (1999)